Kalle Kurppa

Kalle Kurppa

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2018 in Nutrients
Verified
Journal Article
Open access
PDF file
PLPilvi Laurikka
Pilvi Laurikka
SNSamuli Nurminen
Samuli Nurminen
LKLaura Kivelä
Laura Kivelä
KKKalle Kurppa
Kalle Kurppa
Population-based screening studies have shown celiac disease to be one of the most common chronic gastrointestinal diseases. Nevertheless, because of the diverse clinical presentation, the great majority of patients remain unrecognized. Particularly difficult to identify are the multifaceted extraintestinal symptoms that may appear at variable ages. Although the pathogenesis and long-term outcome of these manifestations are still poorly established, there is some evidence that unrecognized celiac disease predisposes to severe complications if not diagnosed and prevented with an early-initiated gluten-free diet. Therefore, it is of utmost importance that physicians of different disciplines learn to recognize celiac disease in individuals with non-gastrointestinal symptoms. In the future, more studies are needed to clarify the factors affecting development and prognosis of the extraintestinal manifestations.

19 November 2019 in Gut
Verified
Journal Article
Open access
PDF file
KLKatri Lindfors
Katri Lindfors
JLJake Lin
Jake Lin
HLHye-Seung Lee
Hye-Seung Lee
HHHeikki Hyöty
Heikki Hyöty
MNMatti Nykter
Matti Nykter
DADaniel Agardh
Daniel Agardh
Objective Higher gluten intake, frequent gastrointestinal infections and adenovirus, enterovirus, rotavirus and reovirus have been proposed as environmental triggers for coeliac disease. However, it is not known whether an interaction exists between the ingested gluten amount and viral exposures in the development of coeliac disease. This study investigated whether distinct viral exposures alone or together with gluten increase the risk of coeliac disease autoimmunity (CDA) in genetically predisposed children. Design The Environmental Determinants of Diabetes in the Young study prospectively followed children carrying the HLA risk haplotypes DQ2 and/or DQ8 and constructed a nested case–control design. From this design, 83 CDA case–control pairs were identified. Median age of CDA was 31 months. Stool samples collected monthly up to the age of 2 years were analysed for virome composition by Illumina next-generation sequencing followed by comprehensive computational virus profiling. Results The cumulative number of stool enteroviral exposures between 1 and 2 years of age was associated with an increased risk for CDA. In addition, there was a significant interaction between cumulative stool enteroviral exposures and gluten consumption. The risk conferred by stool enteroviruses was increased in cases reporting higher gluten intake. Conclusions Frequent exposure to enterovirus between 1 and 2 years of age was associated with increased risk of CDA. The increased risk conferred by the interaction between enteroviruses and higher gluten intake indicate a cumulative effect of these factors in the development of CDA.

30 April 2013 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
PPPilvi Paarlahti
Pilvi Paarlahti
KKKalle Kurppa
Kalle Kurppa
AUAnniina Ukkola
Anniina Ukkola
PCPekka Collin
Pekka Collin
HHHeini Huhtala
Heini Huhtala
KKKatri Kaukinen
Katri Kaukinen
Background: Evidence suggests that many coeliac disease patients suffer from persistent clinical symptoms and reduced health-related quality of life despite a strict gluten-free diet. We aimed to find predictors for these continuous health concerns in long-term treated adult coeliac patients. Methods: In a nationwide study, 596 patients filled validated Gastrointestinal Symptom Rating Scale and Psychological General Well-Being questionnaires and were interviewed regarding demographic data, clinical presentation and treatment of coeliac disease, time and place of diagnosis and presence of coeliac disease-associated or other co-morbidities. Dietary adherence was assessed by a combination of self-reported adherence and serological tests. Odds ratios and 95% confidence intervals were calculated by binary logistic regression. Results: Diagnosis at working age, long duration and severity of symptoms before diagnosis and presence of thyroidal disease, non-coeliac food intolerance or gastrointestinal co-morbidity increased the risk of persistent symptoms. Patients with extraintestinal presentation at diagnosis had fewer current symptoms than subjects with gastrointestinal manifestations. Impaired quality of life was seen in patients with long duration of symptoms before diagnosis and in those with psychiatric, neurologic or gastrointestinal co-morbidities. Patients with persistent symptoms were more likely to have reduced quality of life. Conclusions: There were a variety of factors predisposing to increased symptoms and impaired quality of life in coeliac disease. Based on our results, early diagnosis of the condition and consideration of co-morbidities may help in resolving long-lasting health problems in coeliac disease.

27 December 2018 in Alimentary Pharmacology & Therapeutics
Verified
Journal Article
Open access
PDF file
VFValma Fuchs
Valma Fuchs
KKKalle Kurppa
Kalle Kurppa
HHHeini Huhtala
Heini Huhtala
KLKaija Laurila
Kaija Laurila
MMMarkku Mäki
Markku Mäki
KKKatri Kaukinen
Katri Kaukinen
Summary: Background: The revised paediatric criteria for coeliac disease allow omission of duodenal biopsies in symptomatic children who have specific serology and coeliac disease‐associated genetics. It remains unclear whether this approach is also applicable for adults with various clinical presentations.Aim: To evaluate the accuracy of serology‐based criteria in adults with variable pre‐test probabilities for coeliac disease.Methods: Three study cohorts comprised adults with high‐risk clinical coeliac disease suspicion (n = 421), moderate‐risk family members of coeliac disease patients (n = 2357), and low‐risk subjects from the general population (n = 2722). Serological and clinical data were collected, and “triple criteria” for coeliac disease comprised transglutaminase 2 antibodies >10× the upper limit of normal, positive endomysium antibodies, and appropriate genetics without requirement of symptoms. The diagnosis was based on intestinal biopsy.Results: The diagnosis of coeliac disease was established in 274 subjects. Of these, 59 high‐risk subjects, 17 moderate‐risk subjects, and 14 low‐risk subjects fulfilled the “triple criteria”. All had histologically proven coeliac disease, giving the criteria a positive predictive value of 100%. Altogether, 90 (33%) of all 274 newly diagnosed patients could have avoided biopsy, including 37% among high‐risk, 20% among moderate‐risk, and 48% among low‐risk patients. No histological findings other than coeliac disease were found in the biopsies of “triple positive” subjects.Conclusions: Coeliac disease can reliably and safely be diagnosed without biopsy in adults fulfilling the “triple criteria” regardless of the pre‐test probability. Revised criteria would enable the number of endoscopies to be reduced by one‐third.

1 May 2018 in United European Gastroenterology Journal
Verified
Journal Article
Open access
VFValma Fuchs
Valma Fuchs
KKKalle Kurppa
Kalle Kurppa
HHHeini Huhtala
Heini Huhtala
MMMarkku Mäki
Markku Mäki
LKLeila Kekkonen
Leila Kekkonen
KKKatri Kaukinen
Katri Kaukinen
Background: Celiac disease is challenging to recognize, predisposing to long diagnostic delay. Currently, associated factors and significance of the delay remain obscure.Objective: The objective of this article is to investigate associated sociodemographic risk factors and health consequences of diagnostic delay in celiac disease.Methods: Altogether 611 patients were surveyed at diagnosis and after one year on a gluten‐free diet regarding sociodemographic variables, well‐being and use of medicines and health care services. Quality of life was measured by a validated Psychological General Well‐Being (PGWB) questionnaire. The results were compared between patients with and without delayed (≥3 years) diagnosis.Results: A total of 332 (54%) individuals reported a delay of ≥3 years. Associated with the delay were being a student or homemaker, but not gender, marital or occupational status, site of diagnosis or place of residence. Patients with the delay also had decreased self‐perceived health and poorer PGWB scores compared to those without delay; in anxiety and general health this was seen even on a gluten‐free diet. Days of sickness and doctor visits as well as use of drugs for dyspepsia and antidepressants were increased in the delay group both before and after diagnosis.Conclusion: A delay in celiac disease diagnosis predisposes to reduced well‐being and incremental use of medicines and health care services, both before diagnosis and one year after diagnosis.

1 November 2015 in The Journal of Pediatrics
Verified
Journal Article
Closed access
LKLaura Kivelä
Laura Kivelä
KKKatri Kaukinen
Katri Kaukinen
MLMarja-Leena Lähdeaho
Marja-Leena Lähdeaho
HHHeini Huhtala
Heini Huhtala
MAMerja Ashorn
Merja Ashorn
KKKalle Kurppa
Kalle Kurppa